2009年12月18日
Cediranib Demonstrates Safe, Well Tolerated Antitumour Activity in Patients With Advanced Renal Cell Carcinoma: Presented at EMUC By Chris Berrie BARCELONA, Spain -- December 1, 2009 -- Cediranib is safe and well tolerated, and shows signif...
Tags: